Constitutional Court to hear GC Biopharma's case in 1st complaint against ruling

Home > National > Social Affairs

Published: 28 Apr. 2026, 21:49

GC Biopharma headquarters in Gyeonggi [GC BIOPHARMA]

The Constitutional Court announced Tuesday that it will hear a constitutional complaint by biopharmaceutical company GC Biopharma against a court ruling on a fine levied by the country's antitrust regulator.

It is the first case in which the Constitutional Court will review a finalized ruling under a newly enacted law that allows constitutional complaints against court decisions.

The court has received 525 complaints and rejected 265 of the 266 cases that underwent preliminary review, since the law took effect last month.

The biopharmaceutical company is disputing a Supreme Court ruling that upheld the Fair Trade Commission's fine for rigging vaccine purchase bids between April 2017 and January 2019.

The company had filed an administrative suit against the regulator's decision, but the Supreme Court ultimately rejected it in February without formal deliberation.

The company filed the constitutional complaint against the ruling last month, arguing that the Supreme Court denied its right to a trial.

Yonhap